Brand Awareness Archives - BioMedWire (BMW)

ThursdayDec 04, 2025 9:00 am

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

BioMedWire Editorial Coverage: Chronic illnesses and rare disorders among older Americans represent a rapidly intensifying challenge for the U.S. healthcare system, with the National Institutes of Health estimating that more than 30 million people nationwide are living with a rare disease. Most of these conditions have no FDA-approved therapies, leaving older adults particularly at risk as age-related changes can mask or delay accurate diagnosis. This growing strain on care has heightened the need for novel treatments that address significant unmet medical needs. Soligenix Inc. (NASDAQ: SNGX) (profile), a late-stage biopharmaceutical developer, is advancing several rare-disease therapies, including HyBryte[TM] (synthetic hypericin)…

TuesdayDec 02, 2025 9:00 am

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

BioMedWire Editorial Coverage: Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially as more than 30 million Americans are affected by rare diseases, according to the National Institutes of Health. The vast majority of these conditions lack any FDA-approved treatment, leaving older adults especially vulnerable as age-related symptoms often obscure or delay diagnosis. This rising burden has increased demand for new therapies that can address real unmet need. Soligenix Inc. (NASDAQ: SNGX) (Profile), a late-stage biopharmaceutical company, is developing multiple treatments for rare diseases, including HyBryte[TM] (synthetic hypericin)…

MondayNov 24, 2025 9:00 am

Biotech Valuations Rise as New Clinical Platforms Show Progress

BioMedWire Editorial Coverage: As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles (“GAAP”) are increasingly recognized as meaningful signals of real scientific and business advancement. These valuations help translate research achievements into quantifiable economic impact, giving investors clearer insight into how innovation converts into company value. Oncotelic Therapeutics Inc. (OTCQB: OTLC) (profile) this trend as it prepares for a major fair-value update on its 45% ownership in joint venture (“JV”) partner GMP Bio, following a new independent assessment that points to a substantial increase in the asset’s worth. This development further reinforces Oncotelic…

ThursdayNov 20, 2025 9:00 am

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

BioMedWire Editorial Coverage: As late-stage biotech pipelines mature, fair-value remeasurements under U.S. Generally Accepted Accounting Principles (“GAAP”) are emerging as critical indicators of tangible scientific and commercial progress. These revaluations provide a financial bridge between laboratory breakthroughs and shareholder value, offering investors a clearer picture of how innovation becomes measurable enterprise worth. Oncotelic Therapeutics Inc. (OTCQB: OTLC) (profile) exemplifies this shift as the company prepares for a significant fair-value remeasurement of its 45% stake in joint venture (“JV”) entity GMP Bio, driven by a new independent valuation indicating a potential step-up in asset value. This key shift strengthens Oncotelic Therapeutics position…

ThursdayJul 15, 2021 1:08 pm

Report Finds That Use of Remote Health Has Grown Significantly

A recent survey conducted in the second quarter of this year by Parks Associates has found that more than one-half of broadband households own an internet-enabled fitness or health device that records biometric data, with another two-thirds revealing that they have undergone remote health consultation. The survey, which involved 5,000 broadband households in the United States was conducted by Parks Associates, a market research and consulting firm that specializes in emerging consumer technology products. Parks Associates senior analyst Kristen Hanich stated that the overall familiarity with telehealth had assisted in driving the connected health device market. Hanich noted that there…

TuesdayJun 22, 2021 3:00 pm

Customized Brain Maps Help Boost Cancer, Epilepsy Treatments Outcomes

A team of medical device developers, neuroscientists, surgeons and engineers from the University of California San Diego is working on developing better customized maps that will be useful to physicians during brain tumor removal surgery. Maps do already exist that physicians can reference. However, one individual’s brain isn’t the same as another’s, which is why customized maps are needed. Additionally, an individual’s brain may sometimes reorganize itself as a response to damage caused by things such as growing tumors, which can make it even harder to remove the tumor. This is where sensors enter the picture. Surgical teams can utilize…

FridayJun 18, 2021 2:14 pm

How What You Eat Affects Your Brain Health

A recently released study discovered that individuals who routinely consumed processed meat along with sugary drinks and snacks that were high in sodium tended to have smaller left hippocampi, which is the part of the brain that is responsible for mental health, learning and memory. The study, which was conducted by researchers from the Australian National University and Deakin University, also found that older individuals who consumed healthier diets had larger hippocampi. The researchers concluded that a higher intake of unhealthy food and a lower intake of nutrient-dense foods were each independently linked to a smaller hippocampus volume, noting that…

FridayMay 28, 2021 10:00 am

UM Twin Cities Researchers Find Way to Optimize Immune Response Against Cancer

In what many have described as groundbreaking work, a team of researchers based at University of Minnesota Twin Cities has demonstrated how the body’s immune cells can be engineered in order to navigate the physical barriers that make it hard for an individual’s immune system to fight cancerous tumors. This study has the potential to improve how millions of cancer patients are treated. The research paper was published in the journal “Nature Communications.” Conventionally, cancers are commonly treated through the use of chemicals (chemotherapy), radiation and surgery. Combinations of these approaches are also common. However, immunotherapy is also gaining ground…

TuesdaySep 24, 2019 9:00 am

Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers

BioMedWire Editorial Coverage: Advances in biotechnology look to deliver promising new treatment options against breast cancer. Independent researchers have found that Genprex Inc.’s (NASDAQ: GNPX) (GNPX Profile) TUSC2 prevented tumor growth against triple-negative breast cancer. Eli Lilly and Company (NYSE: LLY) is focusing on those patients with the greatest need and, in the process, has developed a new breast-cancer treatment option. Roche Holding (OTCQX: RHHBY) is expanding the use of its biotech to both identify and treat patients with challenging breast cancers. AbbVie Inc. (NYSE: ABBV) has been rapidly increasing its research, targeting more than 15 different types of cancer.…

WednesdaySep 04, 2019 9:00 am

Gene Therapy Treatments Offer Hope for Cancer Patients

BioMedWire Editorial Coverage: Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is focused on using gene therapy to tackle lung cancer, developing new drugs that can be used alongside existing treatments. Pfizer Inc. (NYSE: PFE) has created a state-of-the-art research center focused on gene therapy treatments, which it uses for illnesses including cancer. Gilead Sciences Inc. (NASDAQ: GILD) is using biotechnology to tackle a range of challenging diseases, including HIV and hepatitis. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is developing 20 different…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Category: Brand Awareness

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

Biotech Valuations Rise as New Clinical Platforms Show Progress

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

Report Finds That Use of Remote Health Has Grown Significantly

Customized Brain Maps Help Boost Cancer, Epilepsy Treatments Outcomes

How What You Eat Affects Your Brain Health

UM Twin Cities Researchers Find Way to Optimize Immune Response Against Cancer

Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers

Gene Therapy Treatments Offer Hope for Cancer Patients

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search